$14.67 0%
Price vs. AI Score (Last 150 days)
Data gathered: December 4

Data Bits

Data Bits Value / Change Benchmark
Job Posts 11 0%
Sentiment 95 -2.1%
Webpage traffic 18,000 17.5%
Employee Rating 79 0%
Google Adspend $ N/A N/A
Google Trends 35 0%
Patents 2 0%
4chan Mentions 0% N/A
Facebook Engagement 480 6.4%
Facebook followers 2,936 0%
Stocktwits Mentions 3 0%
Stocktwits Subscribers 15,625 -0%
Twitter Followers 818 0%
News Mentions 0%
Reddit Mentions 0%
ESG 24 -31.4%
Business outlook 100 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development and commercialization of therapies for people with rare debilitating diseases, chronic neuromuscular and neurological diseases.

Catalyst Pharmaceuticals
Price $14.67
Target Price Sign up
Market Cap $1.58B
Dividend Yield 0.0597
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '23103M48M55M-31M-29M
Q2 '23100M40M59M38M55M
Q1 '2385M46M39M30M42M
Q4 '2261M26M34M25M31M
Q3 '2257M24M33M23M26M

Insider Transactions

MCENANY PATRICK J filed to sell 3,945,436 shares at $13.2.
May 17 '23
Tierney David S filed to sell 313,541 shares at $16.8.
April 7 '23
GRANDE ALICIA filed to sell 50,557 shares at $16.7.
March 30 '23
Del Carmen Jeffrey filed to sell 7,541 shares at $16.7.
March 30 '23
GRANDE ALICIA filed to sell 50,557 shares at $16.5.
March 24 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.